IDH1 and central nervous system cancer: Mutations in isocitrate dehydrogenase 1 and 2 (termed IDH1/2mut) are present in approximately 25–30% of all diffusely infiltrative gliomas in adults, and are now part of the diagnostic criteria for oligodendrogliomas [1].